Fuso Pharmaceutical Industries,Ltd.

Tokyo Stock Exchange 4538.T

Fuso Pharmaceutical Industries,Ltd. Capital Expenditure for the year ending March 31, 2024: USD -23.71 M

Fuso Pharmaceutical Industries,Ltd. Capital Expenditure is USD -23.71 M for the year ending March 31, 2024, a -100.09% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Fuso Pharmaceutical Industries,Ltd. Capital Expenditure for the year ending March 31, 2023 was USD -11.85 M, a 3.01% change year over year.
Fuso Pharmaceutical Industries,Ltd. Capital Expenditure for the year ending March 31, 2022 was USD -12.22 M, a -11.80% change year over year.
Fuso Pharmaceutical Industries,Ltd. Capital Expenditure for the year ending March 31, 2021 was USD -10.93 M, a 53.04% change year over year.
Fuso Pharmaceutical Industries,Ltd. Capital Expenditure for the year ending March 31, 2020 was USD -23.27 M, a -11.29% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Tokyo Stock Exchange: 4538.T

Fuso Pharmaceutical Industries,Ltd.

CEO	Mr. Mikio Toda
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-7-10, Doshomachi
Employees	1,370
Sector	Consumers Staples
Industries Cleaning Supplies Automotive Parts Composite Materials Hardware & Electronics Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics

Description

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.

Key trends

Past 5 years